» Articles » PMID: 27099623

Long-term Effects of Single and Combined Introductions of Antibiotics and Bacteriophages on Populations of Pseudomonas Aeruginosa

Overview
Journal Evol Appl
Specialty Biology
Date 2016 Apr 22
PMID 27099623
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

With escalating resistance to antibiotics, there is an urgent need to develop alternative therapies against bacterial pathogens and pests. One of the most promising is the employment of bacteriophages (phages), which may be highly specific and evolve to counter antiphage resistance. Despite an increased understanding of how phages interact with bacteria, we know very little about how their interactions may be modified in antibiotic environments and, reciprocally, how phage may affect the evolution of antibiotic resistance. We experimentally evaluated the impacts of single and combined applications of antibiotics (different doses and different types) and phages on in vitro evolving populations of the opportunistic pathogen Pseudomonas aeruginosa PAO1. We also assessed the effects of past treatments on bacterial virulence in vivo, employing larvae of Galleria mellonella to survey the treatment consequences for the pathogen. We find a strong synergistic effect of combining antibiotics and phages on bacterial population density and in limiting their recovery rate. Our long-term study establishes that antibiotic dose is important, but that effects are relatively insensitive to antibiotic type. From an applied perspective, our results indicate that phages can contribute to managing antibiotic resistance levels, with limited consequences for the evolution of bacterial virulence.

Citing Articles

Invasions of Host-Associated Microbiome Networks.

Murall C, Abbate J, Touzel M, Allen-Vercoe E, Alizon S, Froissart R Adv Ecol Res. 2024; 57:201-281.

PMID: 39404686 PMC: 7616576. DOI: 10.1016/bs.aecr.2016.11.002.


The role of rhizosphere phages in soil health.

Wang X, Tang Y, Yue X, Wang S, Yang K, Xu Y FEMS Microbiol Ecol. 2024; 100(5).

PMID: 38678007 PMC: 11065364. DOI: 10.1093/femsec/fiae052.


Decolonizing drug-resistant with phage and probiotics: breaking the frequency-dependent dominance of residents.

Forsyth J, Barron N, Scott L, Watson B, Chisnall M, Meaden S Microbiology (Reading). 2023; 169(7).

PMID: 37418300 PMC: 10433417. DOI: 10.1099/mic.0.001352.


"Two Is Better Than One": The Multifactorial Nature of Phage-Antibiotic Combinatorial Treatments Against ESKAPE-Induced Infections.

Fungo G, Uy J, Porciuncula K, Candelario C, Chua D, Gutierrez T Phage (New Rochelle). 2023; 4(2):55-67.

PMID: 37350995 PMC: 10282822. DOI: 10.1089/phage.2023.0007.


Antibiotics that affect translation can antagonize phage infectivity by interfering with the deployment of counter-defenses.

Pons B, Dimitriu T, Westra E, van Houte S Proc Natl Acad Sci U S A. 2023; 120(4):e2216084120.

PMID: 36669116 PMC: 9942909. DOI: 10.1073/pnas.2216084120.


References
1.
Beceiro A, Tomas M, Bou G . Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?. Clin Microbiol Rev. 2013; 26(2):185-230. PMC: 3623377. DOI: 10.1128/CMR.00059-12. View

2.
Seed K, Yen M, Shapiro B, Hilaire I, Charles R, Teng J . Evolutionary consequences of intra-patient phage predation on microbial populations. Elife. 2014; 3:e03497. PMC: 4141277. DOI: 10.7554/eLife.03497. View

3.
Hughes D, Andersson D . Selection of resistance at lethal and non-lethal antibiotic concentrations. Curr Opin Microbiol. 2012; 15(5):555-60. DOI: 10.1016/j.mib.2012.07.005. View

4.
Verbeken G, Pirnay J, Lavigne R, Jennes S, De Vos D, Casteels M . Call for a dedicated European legal framework for bacteriophage therapy. Arch Immunol Ther Exp (Warsz). 2014; 62(2):117-29. PMC: 3950567. DOI: 10.1007/s00005-014-0269-y. View

5.
Lood R, Winer B, Pelzek A, Diez-Martinez R, Thandar M, Euler C . Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model. Antimicrob Agents Chemother. 2015; 59(4):1983-91. PMC: 4356752. DOI: 10.1128/AAC.04641-14. View